# Redcliffe Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/redcliffe-labs

- Industry: Healthcare
- Headquarters: Noida, India
- Website: www.redcliffelabs.com
- Total disclosed funding: $118M
- Latest round: Series C (Sep 17, 2024)
- Investors on record: 9

## About

Redcliffe Labs, based in India, specializes in providing diagnostic services, including health checkups and laboratory testing, catering to both individual patients and healthcare providers.Founded in 2018, Redcliffe Labs operates primarily in Noida, India, delivering a wide range of diagnostic services. The company's founders include Aditya Kandoi, Ashish Dubey, and Dheeraj Jain. The company has engaged in 12 deals, with its latest funding round, Series C, raising INR 3.5 billion on September 17, 2024, led by IFU alongside HealthQuad, Leapfrog Ventures, and Spark Growth Ventures. The total amount raised by the company is INR 3.5 billion.Redcliffe Labs provides an extensive suite of diagnostic services, focusing on health checkups and lab tests. Their offerings include various health packages such as full body checkups and specialized tests for diabetes, thyroid disorders, cancer, and infections. These services aim to facilitate early detection and management of health issues for a diverse clientele, including individual patients and healthcare professionals. The company operates mainly in urban areas of India, including metropolitan regions like Delhi, responding to a growing demand for reliable diagnostic solutions. A mobile app enhances user accessibility, allowing clients to book tests, access reports, and manage appointments efficiently.Redcliffe Labs reported revenue of INR 982,362 in the most recent fiscal year 2023. The company generates revenue through direct-to-consumer transactions for its diagnostic services, with health packages priced according to the complexity and number of tests provided. For instance, a full body checkup is offered at INR 1,799, while a targeted fever package costs INR 1,699. Clients often benefit from promotional offers, fostering customer engagement and loyalty. By combining in-person sample collections with a digital platform for bookings and reports, Redcliffe Labs has developed a scalable revenue model in the competitive healthcare diagnostics sector.In September 2024, Redcliffe Labs secured INR 3.5 billion in Series C funding to support its expansion plans, specifically focusing on increasing its presence in India's Tier II and III cities. The company aims to enhance its product offerings and reach, although specific new product launches have not been detailed as of yet. The recent funding will be instrumental in facilitating this geographic expansion, allowing the company to cater to a broader market segment.

## Funding rounds

- Series C, Sep 17, 2024, $42M — Leapfrog Ventures, Impact Fund Denmark, HealthQuad, Spark Growth Ventures
- Series B, May 6, 2022, $61M — Leapfrog Ventures, Schroders, Chiratae Ventures, Alkemi Growth Capital, HealthQuad, Spark Growth Ventures, LC Nueva Capital
- Series A, Jan 21, 2022, $10M — Spark Growth Ventures
- Seed, Apr 3, 2021, $5M — Asymmetry Ventures
- Series A, Feb 11, 2021, $0.5M — Chiratae Ventures, Alkemi Growth Capital

## Investors

- Chiratae Ventures (https://capitalatlas.ai/funds/chiratae-ventures) — Series A, Series B
- Alkemi Growth Capital (https://capitalatlas.ai/funds/alkemi-growth-capital) — Series A, Series B
- Asymmetry Ventures (https://capitalatlas.ai/funds/asymmetry-ventures) — Seed
- Spark Growth Ventures (https://capitalatlas.ai/funds/spark-growth-ventures) — Series A, Series B, Series C
- Leapfrog Ventures (https://capitalatlas.ai/funds/leapfrog-ventures) — Series B, Series C
- Schroders — Series B
- HealthQuad (https://capitalatlas.ai/funds/healthquad) — Series B, Series C
- LC Nueva Capital (https://capitalatlas.ai/funds/lc-nueva-capital) — Series B
- Impact Fund Denmark (https://capitalatlas.ai/funds/impact-fund-denmark) — Series C